What the study found
The study found that Tmem178, a protein that restricts calcium ion (Ca2+) flux by limiting store-operated calcium entry, suppresses NLRP3 inflammasome activation in osteoclasts, the cells that break down bone. The authors report that this suppression also limits the bone-resorbing activity of osteoclasts.
Why the authors say this matters
The authors conclude that Tmem178 potently restricts Ca2+ influx in osteoclasts, which in turn suppresses NLRP3 inflammasome activation. The findings indicate a mechanism linking calcium handling in osteoclasts to inflammasome-driven bone resorption.
What the researchers tested
The researchers examined NLRP3 levels during osteoclast formation and tested responses to lipopolysaccharide (LPS, a bacterial product) and nigericin, an NLRP3 activator, in macrophages, osteoclasts, and lineage-committed osteoclast precursors. They also studied osteoclasts lacking Tmem178, osteoclasts exposed to high Ca2+ concentrations, and mice in which Nlrp3 was deleted.
What worked and what didn't
NLRP3 abundance decreased during osteoclastogenesis but was restored by LPS treatment. LPS and nigericin activated the inflammasome in macrophages, but not in osteoclasts or their committed precursors; this difference was attributed to Tmem178, which suppressed inflammasome nucleation. Inflammasome activation was strong in Tmem178-deficient osteoclasts and in wild-type osteoclasts exposed to high Ca2+ levels, and deleting Nlrp3 rescued the osteopenic phenotype of Tmem178-/- mice.
What to keep in mind
The abstract does not describe specific experimental limitations or uncertainties beyond the cell types and in vivo mouse conditions studied. The summary is limited to the mechanisms and outcomes explicitly stated in the abstract.
Key points
- Tmem178 was identified as an inhibitor of NLRP3 inflammasome activation in osteoclasts.
- NLRP3 levels fell during osteoclast formation but rose after LPS treatment.
- Macrophages responded to LPS and nigericin, but osteoclasts and their precursors did not.
- Loss of Tmem178 or exposure to high Ca2+ restored strong inflammasome activation in osteoclasts.
- Deleting Nlrp3 rescued the osteopenic phenotype of Tmem178-/- mice.
Disclosure
- Research title:
- Tmem178 suppresses NLRP3 inflammasome activation in osteoclasts
- Authors:
- Khushpreet Kaur, Yael Alippe, C Wang, Nicholas P. Semenkovich, Mohamed Ghassan, Saumya Bhagat, Kunjan Khanna, Y S Li, Nitin Kumar Pokhrel, Timothy R. Peterson, Erica L. Scheller, Deborah J. Veis, Yousef Abu‐Amer, Roberta Faccio, Gabriel Mbalaviele
- Institutions:
- Medical College of Wisconsin, Shriners Hospitals for Children – St. Louis, Technologies pour la Santé, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis, Washington University in St. Louis
- Publication date:
- 2026-04-21
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with scholarly research without reading academic papers — one filtered digest, every Friday.